ATLAS Trial: ‘Carryover’ Effect of Tamoxifen Extends to 15 Years Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:3-4, February 10, 2013. Favorite PDF Permissions Free
Postmenopausal Patients: Letrozole Benefit Varies by Histology and ER-Subtype Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:4-5, February 10, 2013. Favorite PDF Permissions Free
Kathy Albain on the Significance of ATLAS & BIG for Early/Late Tamoxifen Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:5-6, February 10, 2013. Favorite PDF Permissions Free
A New Take on ‘Chemo Brain’ Susman, Ed Susman, Ed Less Oncology Times. 35:6, February 10, 2013. Favorite PDF Permissions Free
Key Takeaways Related to HER2 Therapy Gradishar, William Gradishar, William Less Oncology Times. 35:7-8, February 10, 2013. Favorite PDF Permissions Free
How the Evolving Link Between Science and Advocacy at SABCS has Grown Even Stronger Rosenthal, Eric T. Rosenthal, Eric T. Less Oncology Times. 35:8-9, February 10, 2013. Favorite PDF Permissions Free
Black Patients Less Likely to Receive Sentinel Lymph Node Biopsy, Increasing Lymphedema Risk DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 35:10-11, February 10, 2013. Favorite PDF Permissions Free
BOLERO-2 Study: Everolimus-Exemestane Overcomes Al Resistance Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:11-12, February 10, 2013. Favorite PDF Permissions Free
Key Takeaways about Metastatic Triple-Negative Breast Cancer Morikawa, Aki Morikawa, Aki Less Oncology Times. 35:12-13, February 10, 2013. Favorite PDF Permissions Free
Vitamin D Levels Predict Relapse in Early Breast Cancer Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:13, February 10, 2013. Favorite PDF Permissions Free
Metformin Excitement Slows Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:20, February 10, 2013. Favorite PDF Permissions Free
Key Takeaways about Hormonal Therapy for Metastatic Breast Cancer O'regan, Ruth O'regan, Ruth Less Oncology Times. 35:21-22, February 10, 2013. Favorite PDF Permissions Free
CONFIRM Trial: Confirmation of Clinical Experience that Higher-Dose Fulvestrant is Better than Lower Doses in Advanced ER+ Breast Cancer Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:22, February 10, 2013. Favorite PDF Permissions Free
Key Takeaways about Breast Cancer Biology: Better Therapy Promised for Triple-Negative Breast Cancer Ma, Cynthia X. Ma, Cynthia X. Less Oncology Times. 35:23-24, February 10, 2013. Favorite PDF Permissions Free
Metastatic Breast Cancer: PD 0332991 + Letrozole Triples PFS Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:24-25, February 10, 2013. Favorite PDF Permissions Free
Neoadjuvant Chemotherapy Shown to Benefit Many Younger Women with Breast Cancer Laino, Charlene Laino, Charlene Less Oncology Times. 35:25, February 10, 2013. Favorite PDF Permissions Free
MUSINGS OF A CANCER DOCTOR: Taking Off from San Antonio Sledge, George W. Sledge, George W. Less Oncology Times. 35:26-27, February 10, 2013. Favorite PDF Permissions Free
Routine MRI Use Not Recommended in Managing Breast Cancer Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 35:27, February 10, 2013. Favorite PDF Permissions Free
